Tunatura Apellis Overview – Path To Approval Of Empaveli in PNH Apellis Pharmaceuticals (NASDAQ:APLS) raised ~$150m via its initial public offering (“IPO”) back in November 2017, issuing just over 10.7m share at a price of […]
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and […]
Roper Technologies Inc. (NYSE:ROP) Q4 2022 Results Conference Call January 27, 2023 8:00 AM ET Company Participants Zack Moxcey – Vice President-Investor Relations Neil Hunn – President and Chief Executive Officer Jason Conley – Vice […]
© Copyright 2020-2023 Forex.ca
Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.